<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2176</journal-id>
<journal-title><![CDATA[Revista Cubana de Oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Oftalmol]]></abbrev-journal-title>
<issn>0864-2176</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21762021000400014</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Implante XEN: triple procedimiento, triple éxito]]></article-title>
<article-title xml:lang="en"><![CDATA[XEN implantation: a triple procedure with triple success]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Monroy]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Isanta Otal]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferrandez Arenas]]></surname>
<given-names><![CDATA[Blanca]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fuentemilla Manzanares]]></surname>
<given-names><![CDATA[Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bambó Rubio]]></surname>
<given-names><![CDATA[María Pilar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Miguel Servet Departamento de Oftalmología ]]></institution>
<addr-line><![CDATA[ Zaragoza]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Zaragoza Departamento de Cirugía ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>34</volume>
<numero>4</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21762021000400014&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21762021000400014&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21762021000400014&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El gran desarrollo de la cirugía de glaucoma mínimamente invasiva, conocida como MIGS, ha supuesto una alternativa eficaz en el tratamiento de esta enfermedad, y ha demostrado ser efectiva en la reducción de la presión intraocular. Presentamos a un paciente varón de 51 años con glaucoma en progresión, quien requería tratamiento médico máximo para el control de su enfermedad y en el que se realizó un triple procedimiento quirúrgico: cirugía de retirada de lente intraocular, facoemusificación e implante XEN®. La cirugía fue un éxito. Se consiguió el control tensional y se pudo prescindir completamente del uso de medicación hipotensora, lo que mejoró mucho la calidad de vida de nuestro paciente. La cirugía MIGS es una alternativa muy válida para el manejo del glaucoma. Cuenta con excelentes resultados, beneficios respecto a la cirugía clásica de glaucoma y un buen perfil de seguridad. En este caso clínico, presentamos el implante XEN® como una opción terapéutica útil en un paciente con glaucoma y valoramos sus indicaciones, beneficios y ventajas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Due to its great development, minimally invasive glaucoma surgery (MIGS) has become a useful alternative in the treatment of this condition, proving effective for intraocular pressure reduction. A case is presented of a male 51-year-old patient with glaucoma in progression who required maximum medical treatment to control his disease. The patient underwent a triple surgical procedure: intraocular lens removal surgery, phacoemulsification and XEN® implantation. The surgery was successful: pressure control was achieved and hypotensive medication was completely eliminated, with which the patient's quality of life improved considerably. MIGS is a very valid alternative in glaucoma management, due to its excellent results, benefits with respect to classic glaucoma surgery, and a good safety profile. The clinical case herein presented illustrates the use of XEN® implantation as a useful therapeutic option in a glaucoma patient, and reference is made to its indications, benefits and advantages.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[MIGS]]></kwd>
<kwd lng="es"><![CDATA[glaucoma]]></kwd>
<kwd lng="es"><![CDATA[implante XEN]]></kwd>
<kwd lng="es"><![CDATA[miopía]]></kwd>
<kwd lng="es"><![CDATA[lente intraocular]]></kwd>
<kwd lng="en"><![CDATA[MIGS]]></kwd>
<kwd lng="en"><![CDATA[glaucoma]]></kwd>
<kwd lng="en"><![CDATA[XEN implantation]]></kwd>
<kwd lng="en"><![CDATA[myopia]]></kwd>
<kwd lng="en"><![CDATA[intraocular lens]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hohberger]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Welge-Lüßen]]></surname>
<given-names><![CDATA[UC]]></given-names>
</name>
<name>
<surname><![CDATA[Lämmer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[MIGS therapeutic success of combined Xen Gel Stent implantation with cataract surgery]]></article-title>
<source><![CDATA[Graefes Arch Clin Exp Ophthalmol]]></source>
<year>2018</year>
<page-range>256</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ansari]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An Update on Implants for Minimally Invasive Glaucoma Surgery (MIGS)]]></article-title>
<source><![CDATA[Ophthalmol Ther]]></source>
<year>2017</year>
<page-range>6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sheybani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dick]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[II]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early Clinical Results of a Novel Ab Interno Gel Stent for the Surgical Treatment of Open-angle Glaucoma]]></article-title>
<source><![CDATA[J Glaucoma]]></source>
<year>2016</year>
<page-range>25</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sng]]></surname>
<given-names><![CDATA[CCA]]></given-names>
</name>
<name>
<surname><![CDATA[Chew]]></surname>
<given-names><![CDATA[PTK]]></given-names>
</name>
<name>
<surname><![CDATA[Htoon]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Lun]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Jeyabal]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Case Series of Combined XEN Implantation and Phacoemulsification in Chinese Eyes One-Year Outcomes]]></article-title>
<source><![CDATA[Adv Ther]]></source>
<year>2019</year>
<page-range>36</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tanito]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Matsuzaki]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ikeda]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fujihara]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of surgically induced astigmatism following different glaucoma operations]]></article-title>
<source><![CDATA[Clin Ophthalmol]]></source>
<year>2017</year>
<volume>11</volume>
<page-range>2113</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
